The therapeutic effects of traditional chinese medicine on COVID-19: a narrative review
- PMID: 32974857
- PMCID: PMC7513902
- DOI: 10.1007/s11096-020-01153-7
The therapeutic effects of traditional chinese medicine on COVID-19: a narrative review
Abstract
Background The Coronavirus Disease 2019 (COVID-19) is a new, highly infective virus. In the absence of specific vaccines and antiviral drugs, the China National Health Commission has released a series of COVID-19 treatment guidelines, which include symptomatic treatment, antiviral treatment, and traditional Chinese medicines (TCM). Aim of the review To analyze and summarize the role of TCMs in the treatment of COVID-19. Methods Relevant studies on TCMs related to the study aim were undertaken through a literature search to synthesize the extracted data. Results The China National Health Commission guidelines recommend 15 oral and injectable TCMs for COVID-19. Studies on TCMs have demonstrated that these compounds possess broad-spectrum antiviral and antibacterial properties, and they have certain advantages in the treatment of viral pneumonia and other emergent infectious diseases. Many TCMs also have potent anti-inflammatory and immunomodulatory effects. Treatment based on syndrome differentiation is one of the significant features in TCM. TCM compounds contain a variety of active ingredients that have proven multi-target effects, making it difficult for viruses to develop drug resistance. A variety of clinical pathways are involved in the actions of these TCMs. These properties allow TCMs to be used in the treatment of COVID-19. Conclusion TCMs have been widely used in the treatment of COVID-19 in China. The unique properties of TCM compounds allow TCMs to have a role in the management of COVID-19.
Keywords: COVID-19; Chinese medicine; Coronavirus; Diagnosis; Traditional chinese medicine (TCM); Treatment.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19.Curr Med Chem. 2024;31(21):3118-3131. doi: 10.2174/0929867330666230331084126. Curr Med Chem. 2024. PMID: 36999715 Review.
-
[Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1213-1218. doi: 10.19540/j.cnki.cjcmm.20200206.501. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32281327 Chinese.
-
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32281335 Review. Chinese.
-
Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.Biosci Trends. 2021 Sep 22;15(4):201-204. doi: 10.5582/bst.2021.01263. Epub 2021 Jul 1. Biosci Trends. 2021. PMID: 34193750
-
Bidirectional effects and mechanisms of traditional Chinese medicine.J Ethnopharmacol. 2022 Nov 15;298:115578. doi: 10.1016/j.jep.2022.115578. Epub 2022 Jul 31. J Ethnopharmacol. 2022. PMID: 35917892 Review.
Cited by
-
Plant metabolomics: a new strategy and tool for quality evaluation of Chinese medicinal materials.Chin Med. 2022 Apr 8;17(1):45. doi: 10.1186/s13020-022-00601-y. Chin Med. 2022. PMID: 35395803 Free PMC article. Review.
-
Progress in Traditional Chinese Medicine Against Respiratory Viruses: A Review.Front Pharmacol. 2021 Aug 31;12:743623. doi: 10.3389/fphar.2021.743623. eCollection 2021. Front Pharmacol. 2021. PMID: 34531754 Free PMC article. Review.
-
Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19.Curr Med Chem. 2024;31(21):3118-3131. doi: 10.2174/0929867330666230331084126. Curr Med Chem. 2024. PMID: 36999715 Review.
-
Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research.Res Social Adm Pharm. 2022 Mar;18(3):2524-2528. doi: 10.1016/j.sapharm.2021.05.004. Epub 2021 May 13. Res Social Adm Pharm. 2022. PMID: 33992585 Free PMC article.
-
Do Diet and Dietary Supplements Mitigate Clinical Outcomes in COVID-19?Nutrients. 2022 May 2;14(9):1909. doi: 10.3390/nu14091909. Nutrients. 2022. PMID: 35565876 Free PMC article. Review.
References
-
- Hick JL, Biddinger PD. Novel coronavirus and old lessons—preparing the health system for the pandemic. N Engl J Med. 2020;382(20):e55. - PubMed
-
- World Health Organize (WHO). WHO coronavirus disease (COVID-19) Dashboard [Internet]. Geneva: WHO (2020), August 7. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
-
- The General Office of the National Health and Health Commission and the Office of the State Administration of Traditional Chinese Medicine. Notice on printing and distributing pneumonia diagnosis and treatment program for new coronavirus infection (Trial version 4) [Internet]. Beijing: China; 2020 January 28. www.gov.cn/zhengce/zhengceku/2020-01/28/content_5472673.htm. ISBN: National Health Office Medical Letter (2020) No. 77
-
- The General Office of the National Health and Health Commission and the Office of the State Administration of Traditional Chinese Medicine. Notice on printing and distributing pneumonia diagnosis and treatment program for new coronavirus infection (trial version 5) [Internet]. Beijing: China; 2020 February 5. https://www.gov.cn/zhuanti/2020-02/09/content_5476407.htm. ISBN: National Health Office Medical Letter (2020) No. 117
-
- The General Office of the National Health and Health Commission and the Office of the State Administration of Traditional Chinese Medicine. Notice on printing and distributing pneumonia diagnosis and treatment program for new coronavirus infection (trial version 6) [Internet]. Beijing: China; 2020 February 19. https://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474791.htm. ISBN: National Health Office Medical Letter (2020) No. 145
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical